Annual progress reports of funded research
Finding the missing causes of early-onset breast cancer (2053790)
- Associate Professor Shuai Li (Chief Investigator A)
- University of Melbourne
- Budget: $2,527,271.50
- Funding period: 3 years
Progress report due 30 April 2027
Temporal Molecular Signatures as the Aetiological Drivers of the Increasing Incidence of Early–Onset Colorectal Cancer (2053616)
- Associate Professor Daniel Buchanan (Chief Investigator A)
- University of Melbourne
- Budget: $2,576,382.70
- Funding period: 3 years
Progress report due 30 April 2027
Understanding the drivers of early onset pancreatic cancer in Australia (2053892)
- Professor Tracy Putoczki (Chief Investigator A)
- The Walter and Eliza Hall Institute of Medical Research
- Budget: $1,992,230.10
- Funding period: 3 years
Progress report due 30 April 2027
Next–Generation Screening: a risk–based model for the timely detection and prevention of early–onset colorectal cancer (2053787)
- Associate Professor Erin Symonds (Chief Investigator A)
- Flinders University
- Budget: $2,739,936.60
- Funding period: 3 years
Progress report due 30 April 2027
The METEOR trial: Transforming recovery options in early–onset colorectal cancer (2053738)
- Professor Alexndra McCarthy (Chief Investigator A)
- Griffith University
- Budget: $850,100.40
- Funding period: 3 years
Progress report due 30 April 2027
STRIVE-EOC Strategic Targeting of Resources and InterVentions for Early-Onset Cancers (2053894)
- Dr Jie-Bin Lew (Chief Investigator A)
- University of Sydney
- Budget: $2,183,831.70
- Funding period: 3 years
Progress report due 30 April 2027
Intervening to improve risk and outcomes for Early-Onset incurable non Hodgkin Lymphoma via immune mapping and manipulation: the iLIMM project (2053683)
- Professor Eliza Hawkes (Chief Investigator A)
- La Trobe University
- Budget: $1,981,900.15
- Funding period: 3 years
Progress report due 30 April 2027